FDA

When Matthew Feshbach, then an investor, first heard about a California company developing treatments for a variety of diseases using stem cells derived from a patient’s own fat cells (autologous adipose-derived cells), he thought, That’s the biggest idea I’ve ever heard.

FDA

The announcement last week took just about everyone by surprise. Scott Gottlieb, MD, the FDA’s well-respected commissioner, would be stepping…